J
Jean-Luc Bosson
Researcher at University of Grenoble
Publications - 201
Citations - 5109
Jean-Luc Bosson is an academic researcher from University of Grenoble. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 33, co-authored 163 publications receiving 4442 citations. Previous affiliations of Jean-Luc Bosson include Centre Hospitalier Universitaire de Grenoble & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
Gérald Simonneau,Hervé Sors,Bernard Charbonnier,Y. Page,Jean-Pierre Laaban,Reza Azarian,Marcel Laurent,Jean-Lou Hirsch,Emile Ferrari,Jean-Luc Bosson,Dominique Mottier,Bertrand Beau +11 more
TL;DR: Under the conditions of this study, initial subcutaneous therapy with the low-molecular-weight heparin tinzaparin appeared to be as effective and safe as intravenous unfractionated Heparin in patients with acute pulmonary embolism.
Journal ArticleDOI
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)
Guillaume Charpentier,Pierre-Yves Benhamou,Dured Dardari,Annie Clergeot,Sylvia Franc,Pauline Schaepelynck-Belicar,Bogdan Catargi,V. Melki,Lucy Chaillous,Anne Farret,Jean-Luc Bosson,Alfred Penfornis +11 more
TL;DR: The Diabeo system gives a substantial improvement to metabolic control in chronic, poorly controlled type 1 diabetic patients without requiring more medical time and at a lower overall cost for the patient than usual care.
Journal ArticleDOI
Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs.
Gilbert Ferretti,Jean-Luc Bosson,P D Buffaz,D. Ayanian,C Pison,F. Blanc,F. Carpentier,Patrick H. Carpentier,M Coulomb +8 more
TL;DR: Findings at helical CT allowed accurate diagnosis of acute PE in patients with intermediate probability at V-P scintigraphy and without deep venous thrombosis at duplex sonography of the legs.
Journal ArticleDOI
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study
Jean-Pierre Zarski,Nathalie Sturm,Jérôme Guéchot,Adeline Paris,Elie-Serge Zafrani,Tarik Asselah,Renée-Claude Boisson,Jean-Luc Bosson,Dominique Guyader,Jean-Charles Renversez,Jean-Pierre Bronowicki,Marie-Christine Gelineau,Albert Tran,Candice Trocme,Victor de Ledinghen,Elisabeth Lasnier,Armelle Poujol-Robert,Frédéric Ziegler,Marc Bourlière,Hélène Voitot,Dominique Larrey,Maria Alessandra Rosenthal-Allieri,I. Hubert,François Bailly,Michel Vaubourdolle +24 more
TL;DR: Fibrotest®, interpretable Fibroscan™, Fibrometer®, and Hepascore® perform best and similarly for diagnosis of significant fibrosis and cirrhosis.
Journal ArticleDOI
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial
Francis Couturaud,Olivier Sanchez,Gilles Pernod,Patrick Mismetti,Patrick Jego,Elisabeth Duhamel,Karine Provost,Claire Bal dit Sollier,Emilie Presles,Philippe Castellant,Florence Parent,Pierre-Yves Salaun,Luc Bressollette,Michel Nonent,Philippe Lorillon,Philippe Girard,Karine Lacut,Marie Guegan,Jean-Luc Bosson,Silvy Laporte,Christophe Leroyer,Hervé Decousus,Guy Meyer,Dominique Mottier +23 more
TL;DR: An additional 18 months of treatment with warfarin reduced the composite outcome of recurrent venous thrombosis and major bleeding compared with placebo among patients with a first episode of unprovoked pulmonary embolism, but benefit was not maintained after discontinuation of anticoagulation therapy.